Submitted by mariehelene.cha... on Thu, 12/20/2012 - 17:18
Linda McGoldrick has been appointed interim Chief Executive Officer of IDF until a permanent appointment is made, hopefully by the spring of 2013.
Linda is a global business strategy leader and policy expert in the health care and life sciences sectors. She has held a number of senior roles in European and North American companies, and has extensive experience of serving on the boards of NGOs, charities and public bodies in both Europe and the US.
Submitted by Lorenzo.Piemonte on Wed, 12/19/2012 - 14:20
As part of its World Diabetes Day 2012 celebrations, IDF Life for a Child Programme partner LifeScan, Inc., part of the Johnson & Johnson Family of Diabetes Companies, has generously donated one million test strips to children with diabetes in seven countries (Mali, Zimbabwe, Bangladesh, Nepal, Sri Lanka, Guyana, Guatemala) supported by the Programme.
The Uganda Non-Communicable Disease Alliance (UNCDA) has taken a major step towards advancing a scalable model of integrated community screening and treatment for NCDs. On Saturday, 15 December, UNCDA and key partners organized the first ever Patient Empowerment Day for NCDs.
Submitted by Lorenzo.Piemonte on Mon, 12/17/2012 - 11:51
The International Diabetes Federation’s Life for a Child Programme is pleased to formally announce the formation of the Life for a Child Medical & Scientific Advisory Group. Composed of International and Country Advisors, the Group’s primary function will be to support the Programme in achieving its vision that “No child should die of diabetes”. Over a two year term (2012-14), advisors will:
Submitted by Lorenzo.Piemonte on Thu, 12/06/2012 - 17:47
The IDF BRIDGES programme supports translational research to determine the actions that improve outcomes in different populations. To date, BRIDGES is supporting 38 studies into sustainable community-based interventions for adoption in the real world. The programme is active in 34 countries worldwide, from Belfast to Bamako, Melbourne to Amman.